Medicare Proposal Lacks Cost Data, Imposes Limitations On Industry Rebuttal
This article was originally published in The Gray Sheet
Executive Summary
CMS' omission of cost-and-utilization data related to its hospital outpatient prospective system (OPPS) proposal makes it difficult for device manufacturers to bolster their arguments against a pro-rata reduction.
You may also be interested in...
Concurrent CMS/FDA Review Is “The Real Issue,” Not OPPS Data – Scully
AdvaMed is hoping to assist the Centers for Medicare & Medicaid Services as the agency devises its 2003 outpatient prospective payment system (OPPS) update, but will be forced to do so without the benefit of analyzing data from years past
Concurrent CMS/FDA Review Is “The Real Issue,” Not OPPS Data – Scully
AdvaMed is hoping to assist the Centers for Medicare & Medicaid Services as the agency devises its 2003 outpatient prospective payment system (OPPS) update, but will be forced to do so without the benefit of analyzing data from years past
CMS Defends New-Technology APC Criteria, Guidelines For Eligibility
CMS' Nov. 30 final rule on the outpatient prospective payment system (OPPS) clarifies that a device must involve a comprehensive service, even if billed with other procedures, to be considered eligible for a new-technology ambulatory payment classification (APC)